
From PR Newswire
Novo Nordisk Submits First Recombinant Treatment for Factor XIII Deficiency for U.S. Regulatory Approval
more
From Novartis Pharmaceuticals Canada
Health Canada Approves FLUAD, New Influenza Vaccine for Seniors
more
From Science Daily
An Alzheimer's Vaccine in a Nasal Spray?
more
From Reuters
H1N1 And Bird Flu Virus Produce Dangerous Hybrids
more
From Science Daily
Drug to Fight Tumors Also Fights the Flu and Possibly Other Viruses
more |